BioLase
This article was originally published in The Gray Sheet
Executive Summary
Acquisition of Laser Skin Toner for roughly 1.7 mil. shares of BioLase stock is valued at about $6 mil. LST's laser "no-incision facelift" and stretch-mark removal system, which is currently pending FDA clearance, is anticipated to round out BioLase's newly formed Aesthetic Division and complement its DermaLase hydrokinetic system and Lazer ToothBrush tooth-whitening system, BioLase states